NL-OMON45047已完成4 期
Intravenous immunoglobulin (IVIg) overtreatment in chronic inflammatory demyelinating polyneuropathy (CIDP) - IVIg overtreatment in CIDP: IOC trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Probable or definite CIDP according to the EFNS/PNS criteria 2010
- •2) Stable disease for 6 months (e.g. no progression of disease in last 6 months)
- •3) IVIg treatment for at least 6 months
- •4) IVIg infusion interval of 2 to 6 weeks.
- •5) Age of at least 18 years
排除标准
- •1) Deterioration after IVIg withdrawal in the last 12 months
- •2) Changes in IVIg treatment dose/interval in last 6 months
- •3) Change of additional CIDP treatment, if any, in the last 3 months (e.g. corticosteroids or immunosuppressive treatment)
- •4) A prolonged period (> 6 weeks) of disability increase following an earlier IVIg withdrawal attempt
- •5) History of respiratory failure related to CIDP
- •6) Legally incompetent
- •7) Lack of written informed consent
研究者
相似试验
进行中（未招募）
不适用
Intravenous immunoglobulin overtreatment in CIDPEUCTR2013-005363-52-NLDepartment of Neurology, Academic Medical Center
已完成
不适用
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disordersISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212
进行中（未招募）
1 期
Intravenous immunoglobulin (IVIG) treatment in children with PANS: a clinical trial in South-western SwedeEUCTR2019-004758-27-SEGillberg Neuropsychiatry Centre10
已完成
不适用
Intravenous immunoglobulin therapy combined with Vitamins E and C for Kawasaki DiseaseKawasaki diseaseJPRN-UMIN000037134Fukuoka Children's Hospital Kawasaki disease center20
已完成
不适用
High-dose intravenous immunoglobulin therapy for refractory viral infection after allogeneic hematopoietic stem cell transplantation.JPRN-UMIN000003034Hematology, Osaka City University, Graduate School of Meicine14